Close
Help




JOURNAL

Clinical Medicine Insights: Circulatory, Respiratory and Pulmonary Medicine

Emerging Therapeutic Options for the Management of COPD

Submit a Paper


Clinical Medicine Insights: Circulatory, Respiratory and Pulmonary Medicine 2013:7 7-15

Review

Published on 09 Apr 2013

DOI: 10.4137/CCRPM.S8140


Further metadata provided in PDF



Sign up for email alerts to receive notifications of new articles published in Clinical Medicine Insights: Circulatory, Respiratory and Pulmonary Medicine

Abstract

Chronic obstructive pulmonary disease (COPD) is the fourth leading cause of death worldwide and is projected to be the third by 2020. COPD is characterized by chronic airflow limitation caused by airway inflammation and parenchymal destruction that is usually progressive. Inhaled bronchodilators continue to be the mainstay of the current management of COPD. Safety and efficacy data of the recently approved medications including aclidinium, glycopyrronium, roflumilast, and indacaterol are reviewed here.



Downloads

PDF  (538.25 KB PDF FORMAT)

RIS citation   (ENDNOTE, REFERENCE MANAGER, PROCITE, REFWORKS)

BibTex citation   (BIBDESK, LATEX)

XML




What Your Colleagues Say About Libertas Academica
This is the second time I have submitted a paper to Palliative Care: Research and Treatment for possible publication.  In both instances, my experience with Libertas Academica was very good from submission to acceptance.  The peer reviewers' comments were insightful, very constructive, and extremely helpful.  The author interface was user-friendly.  The publishing process was fast and convenient. I highly recommend this journal.
Dr Liza Manalo (Palliative Care Unit, Cancer Center, The Medical City, Pasig City, Philippines)
More Testimonials

Quick Links


New article and journal news notification services